Piotr Czarny

Medical University of Lodz

Poland

Research Interests

Explore related searches

Professors in Poland Professors in Cancer Biology Cancer Biology professors in Poland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (12)

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (17)

Przemysław Sitarek

Medical University of Lodz

POLAND

View details

Tomasz Śliwiński

Professor

Medical University of Lodz

POLAND

View details

Mariusz Papp

Head of Pharmacology Dept and Behavioural Pharmacology Lab/ Professor

Maj Institute of Pharmacology Polish Academy of Sciences

POLAND

View details

Marcin Kosmalski

Medical University of Lodz

POLAND

View details

Paulina Wigner

Lodz University of Technology

POLAND

View details

Joanna Saluk-Bijak

University of Łódź

POLAND

View details

Maciej Radek

Medical University of Lodz

POLAND

View details

Michal Kacprzak

Medical University of Lodz

POLAND

View details

Małgorzata Gałecka

Medical University of Lodz

POLAND

View details

MAREK WIECZOREK

Professor

University of Łódź

POLAND

View details

Janusz Szemraj

Medical University of Lodz

POLAND

View details

Maciej Jablkowski

Head

Medical University of Lodz

POLAND

View details

Malgorzata Czyz

full professor

Medical University of Lodz

POLAND

View details

Michal Bijak

Head of Centre/Associate Professor

University of Łódź

POLAND

View details

Piotr Gałecki

Medical University of Lodz

POLAND

View details

Marzenna Zielinska

Medical University of Lodz

POLAND

View details

Ewelina Synowiec

Lodz University of Technology

POLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Piotr Czarny

Research Interests

Explore related searches

Contact this professor

Articles (12)

Polθ Inhibitor (ART558) Demonstrates a Synthetic Lethal Effect with PARP and RAD52 Inhibitors in Glioblastoma Cells

Histone Deacetylases (HDAC) Inhibitor—Valproic Acid Sensitizes Human Melanoma Cells to Dacarbazine and PARP Inhibitor

Class I HDAC Inhibition Leads to a Downregulation of FANCD2 and RAD51, and the Eradication of Glioblastoma Cells

Single-Nucleotide Polymorphisms in Base-Excision Repair-Related Genes Involved in the Risk of an Occurrence of Non-Alcoholic Fatty Liver Disease

Single-Nucleotide Polymorphisms in Genes Maintaining the Stability of Mitochondrial DNA Affect the Occurrence, Onset, Severity and Treatment of Major Depressive Disorder

Variations in the Gene Expression Profile in Atherosclerotic Patients with Non-Fatal ACS. A Preliminary Study

Polθ Inhibition: An Anticancer Therapy for HR-Deficient Tumours

Agomelatine Changed the Expression and Methylation Status of Inflammatory Genes in Blood and Brain Structures of Male Wistar Rats after Chronic Mild Stress Procedure

Synthetic Lethality Targeting Polθ

The Coexistence of Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus

Screening Analysis of Platelet miRNA Profile Revealed miR-142-3p as a Potential Biomarker in Modeling the Risk of Acute Coronary Syndrome

The Interplay between Insulin Resistance, Inflammation, Oxidative Stress, Base Excision Repair and Metabolic Syndrome in Nonalcoholic Fatty Liver Disease

Collaborators (17)

Przemysław Sitarek

Tomasz Śliwiński

Mariusz Papp

Marcin Kosmalski

Paulina Wigner

Joanna Saluk-Bijak

Maciej Radek

Michal Kacprzak

Małgorzata Gałecka

MAREK WIECZOREK

Janusz Szemraj

Maciej Jablkowski

Malgorzata Czyz

Michal Bijak

Piotr Gałecki

Marzenna Zielinska

Ewelina Synowiec

Make your next move.